CHARACTERISTICS OF CORONARY ARTERY CONSTRICTION
CHARACTERISTICS OF CORONARY ARTERY CONSTRICTION
批准号:
3082996
负责人:
Joseph A. Vita
金额:
$8.26万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-04-01 至 1995-03-31
关键词:
acetylcholine angiography antiadrenergic agents arginine aspirin bioassay cholesterol coronary artery coronary disorder coronary occlusion /thrombosis coronary vasodilator disease /disorder model heart catheterization human subject lovastatin miniature swine nitric oxide phenylephrine placebos ultrasound blood flow measurement vasomotion
中文摘要
最近的研究表明,动脉粥样硬化的功能异常
冠状动脉有助于心肌缺血的产生,
产生收缩和/或血栓形成。 现在很清楚,
血管内皮在控制血管张力方面发挥着核心作用,
动脉粥样硬化对内皮血管扩张剂有不利影响
功能 在建议的培训期内,申请人须测试
血管内皮功能紊乱假说
导致冠状动脉收缩
临床相关刺激,这些干扰是可逆的。
血管内皮依赖性舒张反应的前体--L-精氨酸对内皮细胞增殖的影响
因子,EDRF)对增加血流量和输注
将在患有冠状动脉疾病的患者中检查苯丙氨酸
接受心导管插入术 将通过以下方式评估动脉功能:
输注内皮依赖性药物并检查直径反应,
多普勒血流导管定量血管造影和血流反应。 一
建议进行一项安慰剂对照试验,以确定是否减少
血清胆固醇水平的降低可以改善冠状动脉血管舒张功能
在患者中发挥作用。 申请人建议进一步审查这些
动物模型中的问题(胆固醇喂养/球囊损伤的微型
猪)。 髂动脉和冠状动脉的血管反应
动脉粥样硬化中增加的血流量和注入的儿茶酚胺将是
在用L-精氨酸,单甲基精氨酸,
精氨酸、亚甲蓝和特异性肾上腺素能拮抗剂。 动脉
然后将切除节段用于器官室中的研究,提供
有机会关联这些实验方法,并确定
平滑肌功能障碍在这些反应中的重要性。 问题
将通过检查来研究功能异常的可逆性
在胆固醇喂养期间和在
回归分析 培训期间将提供机会,
申请人作为临床研究者发展新的技能和经验
在缺血性心脏病领域。 申请人建议,这些
研究将提供对病理机制的深入了解,并提出新的
冠状动脉疾病患者的管理方法。
英文摘要
Recent studies have shown that functional abnormalities of atherosclerotic
coronary arteries contribute to the production of myocardial ischemia by
producing constriction and/or thrombus formation. It is now clear that the
vascular endothelium plays a central role in controlling vascular tone and
that atherosclerosis has an adverse effect on endothelial vasodilator
function. In the proposed training period, the applicant will test the
hypothesis that disturbance of the vasomotor function of the endothelium
contributes to the production of coronary artery constriction in response
to clinically relevant stimuli and that these disturbances are reversible.
The effect of L-arginine (the precursor of endothelium-dependent relexating
factor, EDRF) on the response to increased blood flow and infused
phenylephrine will be examined in patients with coronary artery disease
undergoing cardiac catheterization. Arterial function will be assessed by
infusing endothelium-dependent agents and examining diameter responses with
quantitative angiography and flow responses with Doppler-flow catheter. A
placebo-controlled trial is proposed that will determine whether reduction
of serum cholesterol can produce an improvement in coronary vasodilator
function in patients. The applicant proposes to further examine these
issues in an animal model (cholesterol-fed/balloon-injured miniature
swine). The vasomotor responses of the iliac and coronary arteries to
increased blood flow and infused catecholamines in atherosclerosis will be
studied before and after treatment with L-arginine, mono-methyl arginine,
D-arginine, methylene blue and specific adrenergic antagonists. Arterial
segments will then be excised for study in the organ chamber, providing an
opportunity to correlate these experimental methods and to determine the
importance of smooth muscle dysfunction in these responses. The issue of
reversibility of functional abnormalities will be studied by examining
diameter responses in the same animal during cholesterol feeding and during
regression. The period of training will provide an opportunity for the
applicant to develop new skills and experience as a clinical investigator
in the field of ischemic heart disease. The applicant proposes that these
studies will provide insight into pathologic mechanisms and suggest new
approaches for management of patients with coronary artery disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial Dynamics and UCP2 - Endothelial Dysfunction in Human Obesity
-
批准号:8583774
-
项目类别:
-
资助金额:$55.53万
-
财政年份:2013
-
负责人:Joseph A. Vita
-
依托单位:
MITOCHONDRIAL DYSFUNCTION IN THE DIABETIC ENDOTHELIUM
-
批准号:8109656
-
项目类别:
-
资助金额:$58.83万
-
财政年份:2011
-
负责人:Joseph A. Vita
-
依托单位:
Boston University Medical Center Leadership Program in Vascular Medicine
-
批准号:7566010
-
项目类别:
-
资助金额:$117.55万
-
财政年份:2007
-
负责人:Joseph A. Vita
-
依托单位:
Boston University Medical Center Leadership Program in Vascular Medicine
-
批准号:7351857
-
项目类别:
-
资助金额:$81.03万
-
财政年份:2007
-
负责人:Joseph A. Vita
-
依托单位:
Boston University Medical Center Leadership Program in Vascular Medicine
-
批准号:7767681
-
项目类别:
-
资助金额:$42.71万
-
财政年份:2007
-
负责人:Joseph A. Vita
-
依托单位:
Boston University Medical Center Leadership Program in Vascular Medicine
-
批准号:7066895
-
项目类别:
-
资助金额:$37.8万
-
财政年份:2007
-
负责人:Joseph A. Vita
-
依托单位:
Determinants of Shear Stress-Mediated Arterial Remodeling
-
批准号:7452358
-
项目类别:
-
资助金额:$47.74万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Vascular Consequences of Insulin Resistance and Obesity
-
批准号:7851079
-
项目类别:
-
资助金额:$235.15万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Vascular Consequences of Insulin Resistance and Obesity
-
批准号:7621045
-
项目类别:
-
资助金额:$228.82万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Administrative Core
-
批准号:7140910
-
项目类别:
-
资助金额:$15.74万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Determinants of Shear Stress-Mediated Arterial Remodeling
-
批准号:7278281
-
项目类别:
-
资助金额:$47.67万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Determinants of Shear Stress-Mediated Arterial Remodeling
-
批准号:7141989
-
项目类别:
-
资助金额:$47.8万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Vascular Consequences of Insulin Resistance and Obesity
-
批准号:7066974
-
项目类别:
-
资助金额:$218.53万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Mechanisms of Vascular Dysfunction in Acute Insulin Resistance
-
批准号:7140900
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Determinants of Shear Stress-Mediated Arterial Remodeling
-
批准号:7640935
-
项目类别:
-
资助金额:$49.8万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Vascular Consequences of Insulin Resistance and Obesity
-
批准号:7227535
-
项目类别:
-
资助金额:$216.23万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Vascular Consequences of Insulin Resistance and Obesity
-
批准号:7418248
-
项目类别:
-
资助金额:$218.0万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Mitochondrial Metabolism and Endothelial Dysfunction
-
批准号:7137205
-
项目类别:
-
资助金额:$48.17万
-
财政年份:2005
-
负责人:Joseph A. Vita
-
依托单位:
Clinical Utility of Endothelial Function in PAD
-
批准号:6942746
-
项目类别:
-
资助金额:$99.96万
-
财政年份:2003
-
负责人:Joseph A. Vita
-
依托单位:
Clinical Utility of Endothelial Function in PAD
-
批准号:6730929
-
项目类别:
-
资助金额:$99.99万
-
财政年份:2003
-
负责人:Joseph A. Vita
-
依托单位:
海外基金